ArticleFrontiers in microbiology2020
A
Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 32 citations in OpenAlex.
- Hypermucoviscosity inJournal of bacteriology · 2026Review
- Genomic convergence of mobilome-associated multidrug resistance and host-adaptation determinants in a postoperativeFrontiers in cellular and infection microbiology · 2026Article
- Phenotypic and genome-based characterization ofFrontiers in microbiology · 2026Article
- Whole-genome sequence analysis of a clinical hypervirulentFrontiers in microbiology · 2026Article
- The promising activity of apple cider vinegar on MDR Klebsiella spp. (K. variicola and K. pneumoniae) emerging pathogens in chicken.Veterinary research communications · 2025Article
- Characterization of Antimicrobial Resistance and Hypervirulent Traits ofAntibiotics (Basel, Switzerland) · 2025Article
- Complete genome sequence of multidrug-resistant and NDM-producingMicrobiology resource announcements · 2025Article
- Emerging Mobile Colistin Resistance GeneInfection and drug resistance · 2025Article
- Transposon mutagenesis screen ineLife · 2024Article
- Comprehensive study reveals phenotypic heterogeneity in Klebsiella pneumoniae species complex isolates.Scientific reports · 2024Article
- Global Emergence and Genomic Epidemiology ofInfection and drug resistance · 2024Article
- Genome sequence of a virulent and hypermucoviscous-like Klebsiella michiganensis clinical isolate.BMC research notes · 2023Article
- A case report of fatal COVID-19 complicated by rapidly progressive sepsis caused by Klebsiella variicola.BMC infectious diseases · 2023Article
- Characteristics of EnvironmentalPharmaceutics · 2023Article
- Class 1 integrons and multiple mobile genetic elements in clinical isolates of theFrontiers in microbiology · 2023Article
- Accurate Identification of Klebsiella variicola by MALDI-TOF Mass Spectrometry in Clinical Microbiology Laboratories.Microbiology spectrum · 2022Article
- Characterization of Novel Bacteriophage vB_KpnP_ZX1 and Its Depolymerases with Therapeutic Potential for K57Pharmaceutics · 2022Article
- Extensively Drug-Resistant Klebsiella pneumoniae Counteracts Fitness and Virulence Costs That Accompanied Ceftazidime-Avibactam Resistance Acquisition.Microbiology spectrum · 2022Article
- Fatal community-acquired bloodstream infection caused byWorld journal of clinical cases · 2022Article
- Unveiling lignocellulolytic trait of a goat omasum inhabitant Klebsiella variicola strain HSTU-AAM51 in light of biochemical and genome analyses.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypermucoviscosity (hmv) is a capsule-associated phenotype usually linked with hypervirulent
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.